RM Global is an investment banking and strategic advisory firm dedicated to creating unique value for its clients and investors. We specialize in Life Sciences, including pharmaceuticals, medical devices, biotechnology, healthcare IT/digital health, and diagnostics. Our broad international reach includes the Americas, Europe, Israel, and Asia.

Since 1992, our diverse team of accomplished professionals has worked closely with life science companies ranging from start-ups to multinationals, providing unbiased strategic and corporate finance support, based upon our comprehensive industry experience. The business which our leadership established has achieved over $3 billion in M&A and strategic transactions and raised nearly $500 million in private growth and venture capital for our clients. We take pride in our long term relationships with our clients that span many years.

In May 2017 we established RMGP Biopharma Investment Management dedicated to the FutuRx platform. Our extensive experience and expertise in the Life Sciences and financial fields has allowed us to provide financial support to the companies at FutuRx and provide our investors with unique access to one of the most exciting early-stage biopharma portfolios we have seen.

We leverage our extensive global network of leading corporations, investment funds, institutional and strategic investors, family offices, industry experts and management teams to source and execute transactions that build new opportunities for our clients worldwide.